Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Teal Valley T.TV


Primary Symbol: P.TEAL

Teal is a Canadian, pharmaceutical & NHP manufacturer selling to Canada’s national, chain drug stores, presently expanding its portfolio to include cannabinoid-based products utilizing proprietary formulations & extractions for both the global Rx & recreational markets.


P.TEAL - Post by User

Comment by Riggedmktson Jan 25, 2022 3:16pm
231 Views
Post# 34359315

RE:Revised 2022 EPS with added calculation for AISC, Cash Flow

RE:Revised 2022 EPS with added calculation for AISC, Cash Flow

Respectfully, I don't believe your "mine operating expense" of $0.92 includes DDA. As the result, the projected net income and the taxes are too high. When you add DDA to the cash flow statement, you overstate operating cash flows.

FWIW, I estimate that at $1.50/lb Zn in 2022 they make just enough to pay $20MM for RP2 early works. On the positive side, they now probably have less than $60MM in net debt, so as long as they can extend the revolver at $120MM and get the Glencore facility to $33MM, they should have enough for RP2.

JMHO.

<< Previous
Bullboard Posts
Next >>